Verified Nov 2026
Other
·

Cary, North Carolina
·
Since 2002
Veloxis Pharmaceuticals is a specialty pharmaceutical company headquartered in Cary, North Carolina, founded in 2002, with 200–500 employees. Part of Asahi Kasei Corporation, it focuses on transplant medicine and immunocompromised patient care. The company markets ENVARSUS XR®, an extended-release tacrolimus for kidney transplant recipients, and is advancing investigational candidates in infectious disease and transplant rejection prevention.
Veloxis Pharmaceuticals, Inc. at a glance
Employees
200-500
Founded
2002
Headquarters
Cary, North Carolina
Industries
Automotive
Electric Vehicles
Medical
Overview
Veloxis Pharmaceuticals is a specialty pharmaceutical company headquartered in Cary, North Carolina, founded in 2002, with 200–500 employees. Part of Asahi Kasei Corporation, it focuses on transplant medicine and immunocompromised patient care. The company markets ENVARSUS XR®, an extended-release tacrolimus for kidney transplant recipients, and is advancing investigational candidates in infectious disease and transplant rejection prevention.
At a glance
Attribute | Detail |
|---|---|
Founded | 2002 |
Headquarters | Cary, North Carolina |
Employees | 200-500 |
What Veloxis Pharmaceuticals, Inc. makes
The company employs proprietary MeltDose® technology for drug formulation and delivery, with capabilities spanning research, development, commercialization, and patient support in transplant care.
Latest developments
2026-09-29 — We are excited to be joining Calliditas Therapeutics and Aicuris Anti-Infective Cures as part of Asahi Kasei Therapeutics! Follow us there to stay up to date on our progress to positively impact … | Veloxis Pharmaceuticals, Inc. (linkedin.com)
2026-08-31 — Veloxis Pharmaceuticals Doses First Patient in RENGEVITY-201 Phase 2 Trial of Pegrizeprument for the Prevention of Organ Rejection in Kidney Transplant Recipients – Asahi Kasei Therapeutics (aktx.com)
2026-08-10 — Office of Public Affairs | Veloxis Pharmaceuticals Agrees to Pay Over $46M to Resolve Criminal and Civil Liability for Kickback Schemes | United States Department of Justice (justice.gov)
2026-04-20 — Asahi Kasei Completes Acquisition of Aicuris to Advance Its Global Pharmaceutical Strategy | Veloxis Pharmaceuticals, Inc. (veloxis.com)
2026-02-01 — Freshfields advises Veloxis and Asahi Kasei on €780m acquisition of AiCuris | Freshfields (freshfields.com)
2026-01-27 — Pirche (pirche.com)
Facilities
Veloxis Pharmaceuticals, Inc. is headquartered in Cary, North Carolina. Public sources also reference these locations:
Cary, North Carolina — pharmacompass.com
Company details
Veloxis operates as part of Asahi Kasei Therapeutics following its parent company's integration with Calliditas Therapeutics and Aicuris Anti-Infective Cures. Veloxis Pharmaceuticals, Inc. was founded in 2002, has an estimated 200-500 employees, and is headquartered in Cary, North Carolina.
Frequently asked questions
What does Veloxis Pharmaceuticals, Inc. do?
Veloxis Pharmaceuticals is a specialty pharmaceutical company headquartered in Cary, North Carolina, founded in 2002, with 200–500 employees. Part of Asahi Kasei Corporation, it focuses on transplant medicine and immunocompromised patient care. The company markets ENVARSUS XR®, an extended-release tacrolimus for kidney transplant recipients, and is advancing investigational candidates in infectious disease and transplant rejection prevention.
Where is Veloxis Pharmaceuticals, Inc. headquartered?
Veloxis Pharmaceuticals, Inc. is headquartered in Cary, North Carolina (2000 Regency Pkwy, Cary, North Carolina, 27518-0005).
When was Veloxis Pharmaceuticals, Inc. founded?
Veloxis Pharmaceuticals, Inc. was founded in 2002.
How big is Veloxis Pharmaceuticals, Inc.?
Veloxis Pharmaceuticals, Inc. has an estimated 200-500 employees.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
